Reduced Serum Levels of Anti-Müllerian Hormone in Females With Inherited Bone Marrow Failure Syndromes | Zendy

Martha M. Sklavos | Zendy; Pamela Stratton | Zendy; Neelam Giri | Zendy; Blanche P. Alter | Zendy; Sharon A. Savage | Zendy; Lígia A. Pinto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reduced Serum Levels of Anti-Müllerian Hormone in Females With Inherited Bone Marrow Failure Syndromes

Author(s) -

Martha M. Sklavos,

Pamela Stratton,

Neelam Giri,

Blanche P. Alter,

Sharon A. Savage,

Lígia A. Pinto

Publication year - 2014

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-2838

Subject(s) - medicine , anti müllerian hormone , fanconi anemia , bone marrow failure , anemia , bone marrow , ovarian reserve , endocrinology , gastroenterology , hormone , cancer , pregnancy , haematopoiesis , stem cell , biology , infertility , biochemistry , genetics , dna repair , gene

Previously, reduced levels of anti-Müllerian hormone (AMH), a circulating marker of ovarian reserve, were found in females with Fanconi anemia (FA). FA, dyskeratosis congenita (DC), and Diamond-Blackfan anemia (DBA) are inherited bone marrow failure syndromes (IBMFS) associated with high risks of bone marrow failure, leukemia, and solid tumors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research